Prathiba Singh, Vaidyanathan, Sibal win biosimilar drug battle for Biocon, Mylan in Delhi HC

The Delhi High Court yesterday gave the go-ahead to Bangalore-based pharma company Biocon and US-based Mylan Inc. to manufacture and sell their biosimilar drugs for the treatment of early breast cancer and metastatic gastric cancer.

Loading content, please wait...
Bar and Bench - Indian Legal news